Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma

被引：37
|
作者：
Lee, Sung Won [1 ,2 ]
Choi, Jonggi [3 ]
Kim, Seung Up [4 ,5 ]
Lim, Young-Suk [3 ]
机构：
[1] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea
[2] Catholic Univ, Liver Res Ctr, Seoul, South Korea
[3] Univ Ulsan, Liver Ctr, Asan Med Ctr, Dept Gastroenterol,Coll Med, Seoul, South Korea
[4] Yonsei Univ, Inst Gastroenterol, Dept Internal Med, Coll Med, Seoul, South Korea
[5] Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2021年 / 27卷 / 03期
关键词：
Entecavir; Tenofovir; Hepatitis B; Carcinoma; Hepatocellular; Efficacy; Outcome; DISOPROXIL FUMARATE; RISK; CIRRHOSIS;
D O I：
10.3350/cmh.2021.0179
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Over the past several decades, entecavir (ETV) and tenofovir disoproxil fumarate (TDF) have remained the first-line antiviral agents in several international guidelines. These two antiviral agents have shown similar short to intermediate-term efficacy, including virologic, biochemical, serologic, and histologic responses. However, huge controversies regarding the antiviral efficacy of ETV and TDF in preventing the development of hepatocellular carcinoma (HCC) still exist. In this review, we summarized recent studies that compared the treatment efficacy of ETV and TDF in terms of HCC development.
引用
收藏
页码：402 / 412
页数：11
相关论文
共 50 条
  • [1] Tenofovir versus entecavir in prevention of hepatocellular carcinoma and mortality in patients with chronic hepatitis B
    Kamal, Faisal
    Khan, Muhammad Ali
    Ahmed, Aijaz
    Nair, Satheesh
    GUT, 2020, 69 (11) : 2054 - +
  • [2] Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B
    Hsu, Yao-Chun
    Wong, Grace Lai-Hung
    Chen, Chong
    Peng, Cheng-Yuan
    Yeh, Ming-Lun
    Cheung, Ka-Shing
    Toyoda, Hidenori
    Huang, Chung-Feng
    Huy Trinh
    Xie, Qing
    Enomoto, Masaru
    Liu, Li
    Yasuda, Satoshi
    Tanaka, Yasuhito
    Kozuka, Ritsuzo
    Tsai, Pei-Chien
    Huang, Yen-Tsung
    Wong, Christopher
    Huang, Rui
    Jang, Tyng-Yuan
    Hoang, Joseph
    Yang, Hwai-, I
    Li, Jiayi
    Lee, Dong-Hyun
    Takahashi, Hirokazu
    Zhang, Jian Q.
    Ogawa, Eiichi
    Zhao, Changqing
    Liu, Chenghai
    Furusyo, Norihiro
    Eguchi, Yuichiro
    Wong, Clifford
    Wu, Chao
    Kumada, Takashi
    Yuen, Man-Fung
    Yu, Ming-Lung
    Nguyen, Mindie H.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (02): : 271 - 280
  • [3] TENOFOVIR VERSUS ENTECAVIR FOR HEPATOCELLULAR CARCINOMA PREVENTION IN AN INTERNATIONAL CONSORTIUM OF CHRONIC HEPATITIS B
    Hsu, Yao-Chun
    Wong, Grace Lai-Hung
    Chen, Chien Hung
    Peng, Cheng-Yuan
    Yeh, Ming-Lun
    Cheung, Ka-Shing
    Toyoda, Hidenori
    Huang, Chung-Feng
    Trinh, Huy N.
    Xie, Qing
    Enomoto, Masaru
    Liu, Li
    Yasuda, Satoshi
    Tanaka, Yasuhito
    Kozuka, Ritsuzo
    Tsai, Pei-Chien
    Huang, Yen-Tsung
    Wong, Christopher
    Huang, Rui
    Jang, Tyng-Yuan
    Hoang, Joseph
    Yang, Hwai-I
    Li, Jiayi
    Lee, Dong Hyun
    Takahashi, Hirokazu
    Zhang, Jianqing
    Ogawa, Eiichi
    Zhao, Changqing
    Liu, Chenghai
    Furusyo, Norihiro
    Eguchi, Yuichiro
    Wong, Clifford
    Wu, Chao
    Kumada, Takashi
    Yuen, Man-Fung
    Yu, Ming-Lung
    Nguyen, Mindie H.
    HEPATOLOGY, 2019, 70 : 290A - 291A
  • [4] Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B
    Choi, Won-Mook
    Choi, Jonggi
    Wong, Grace Lai-Hung
    Han, Seungbong
    Lim, Young-Suk
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (02): : 87 - 87
  • [5] Comparison of Tenofovir and Entecavir in the Prevention of Hepatocellular Carcinoma Occurrence in Patients with Chronic Hepatitis B
    Facciorusso, Antonio
    Cincione, Ivan
    Sacco, Rodolfo
    LIVER CANCER, 2021, 10 (03) : 285 - 286
  • [6] Entecavir versus Tenofovir for the Prevention of Hepatocellular Carcinoma in Treatment-naive Chronic Hepatitis B Patients in Korea
    Choi, HeeKyoung
    Seo, Gi Hyeon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (14) : 1 - 10
  • [7] Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B?
    Yuan, Bao-Hong
    Zhu, Yan-Kun
    Li, Ru-Hong
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (02) : 314 - 315
  • [8] Is tenofovir disoproxil fumarate superior to entecavir for prevention of hepatocellular carcinoma in patients with chronic hepatitis B?
    van Velsen, Lisa M.
    Sonneveld, Milan J.
    van Erpecum, Karel J.
    HEPATOBILIARY SURGERY AND NUTRITION, 2023, 12 (06) : 919 - 922
  • [9] Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
    Lee, Han Ah
    Seo, Yeon Seok
    Kim, Seung Up
    GASTROENTEROLOGY, 2020, 158 (08) : 2310 - 2311
  • [10] Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis
    Huang, Rui
    Liu, Jiacheng
    Wang, Jian
    Wu, Chao
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (09) : 1040 - 1041
12345